MediNect Ophtho - contract partners in ophthalmic drug development
MediNect Ophtho (www.medinect.co.uk) are an independent provider of ophthalmic drug development and expertise. Integrating the experience of leaders in the field of ophthalmology with experienced ophthalmic post-doctoral scientists, we deliver a premium quality service from study design to study execution and data analysis.
MediNect's capabilities focus on utilising our well-established longstanding and novel in vivo retinal disease models to aid your POC, DMPK and ADME studies.
Company Details
- Employees
- 11
- Founded
- -
- Address
- 97 Lisburn Road, Belfast,northern Ireland,united Kingdom
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- http://www.medinect.co.uk
- HQ
- Belfast, Northern Ireland
Medinect Ophtho Questions
Medinect Ophtho's website is http://www.medinect.co.uk
Medinect Ophtho's LinkedIn profile is https://uk.linkedin.com/company/medinect-ophtho
Medinect Ophtho has
11 employees.
View email and phone details for 11
employees at Medinect Ophtho.
Medinect Ophtho's industry is
Biotechnology Research
Medinect Ophtho's top competitors are
Celerion,
Diaceutics Plc,
Axis Bioservices Limited,
Re-Vana Therapeutics,
Cv6 Therapeutics, (Ni) Ltd.,
Amply Discovery,
Fusion Antibodies,
Phion Therapeutics,
Vascversa Ltd,
Proaxsis.
Medinect Ophtho's categories are Biotechnology Research
Medinect Ophtho's founding year is 2022
